EUVIMEDEUVIMED entdecken
Crossref

Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs

Morgan R L Lichtenstein iD, Peter Campbell, Rohit Raghunathan, Melissa Beauchemin iD, Elena B Elkin iD, Katherine D Crew iD, Melissa Accordino iD, Cindy Ippoliti, Michelle Hwang, Rachel Abramova, Erik Harden iD, Paige Kelly und 4 weitere

JCO Oncology Practice · 2025

DOI: 10.1200/op.24.00326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Morgan R L Lichtenstein und 15 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Pharmacists, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The past decade has seen an increase in oral anticancer drug (OACD) approvals. Polypharmacy and drug-drug interactions (DDIs) likely contribute to OACD toxicity. We assessed a one-time pharmacist-led video consultation to identify DDIs. METHODS We conducted a single-arm telehealth intervention of a one-time 30-minute pharmacist-led video consultation among patients initiating OACDs. The visit focused on identifying polypharmacy and DDIs. Feasibility was defined as ≥50% completion of all study interventions. We determined the prevalence, characteristics, and severity of OACD-related potential DDIs. We also assessed the prevalence of medication list inaccuracies, polypharmacy, patient satisfaction, and patient perception of intervention acceptability, appropriateness, and feasibility. RESULTS Of 58 eligible patients, 43 (74%) completed the intervention and 33 (57%) completed all evaluations. Median medication per patient was nine (range 4-21), and 98% of patients had at least five prescriptions. The median number of medication list errors was two (range 0-16), with at least one error for 76% and >1 for 52%. Pharmacists identified OACD-related interactions in 18 cases (42%), including change in drug metabolism (eight), elimination (one), and absorption (three). Interactions were classified as Lexicomp categories C (13), D (five), or X (one) requiring close monitoring or a change in treatment. All patients expressed high satisfaction with the intervention and agreed or completely agreed that it was acceptable, appropriate, and feasible. CONCLUSION Polypharmacy, medication list errors, and DDIs are prevalent among patients initiating OACDs. A one-time remote pharmacist-led video consultation can address OACD-related DDIs, which may decrease medication complexity and improve adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsAntineoplastic AgentsHumansDrug InteractionsFemaleMaleAgedMiddle AgedAdministration, OralPolypharmacyAged, 80 and overReferral and ConsultationAdultTelemedicine

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.
  • Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY.
  • Merck & Co, Rahway, NJ.
  • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY.

ORCID-Profile: Morgan R L Lichtenstein, Melissa Beauchemin, Elena B Elkin, Katherine D Crew, Melissa Accordino, Erik Harden, Nicole Collins, Jason D Wright, Dawn L Hershman

Zitieren

APA

Lichtenstein, M. R. L., Campbell, P., Raghunathan, R., Beauchemin, M., Elkin, E. B., Crew, K. D., Accordino, M., Ippoliti, C., Hwang, M., Abramova, R., Harden, E., Kelly, P., Collins, N., Faheem, K., Wright, J. D., & Hershman, D. L. (2025). Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs. JCO Oncology Practice. https://doi.org/10.1200/op.24.00326

Vancouver

Lichtenstein MRL, Campbell P, Raghunathan R, Beauchemin M, Elkin EB, Crew KD, et al. Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs. JCO Oncology Practice. 2025. doi:10.1200/op.24.00326

BibTeX
@article{Lichtenstein2025,
  author = {Lichtenstein, Morgan R L and Campbell, Peter and Raghunathan, Rohit and Beauchemin, Melissa and Elkin, Elena B and Crew, Katherine D and Accordino, Melissa and Ippoliti, Cindy and Hwang, Michelle and Abramova, Rachel and Harden, Erik and Kelly, Paige and Collins, Nicole and Faheem, Khadija and Wright, Jason D and Hershman, Dawn L},
  title = {Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op.24.00326}
}
Kostenlos starten →